Aptus Pharma's Board approved increasing Authorized Share Capital from ₹7.15 crore to ₹25 crore, subject to member approval.
Board recommended a 3:2 bonus equity share issue, offering 3 bonus shares for every 2 existing fully paid-up shares held.
Postal Ballot via remote e-voting approved; CDSL appointed as e-voting agency for both resolutions.